Assisted Reproductive Technology (ART) Market: By technology (In-Vitro Fertilization, Artificial Insemination, Surrogacy, Others),By Procedure (Fresh Non donor,Fresh Donor,Frozen Non Donor,Frozen Donor,Embryo Banking), End Users (Hospitals,Fertility Clinics,Others),and Geography –Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2020 and Forecast 2021-2027

 

The global assisted reproductive technology (ART) market is expected to grow at a CAGR of 7.7% during the forecast period 2021 to 2027. Assisted Reproductive Technology (ART) is a treatment for infertility, performed to achieve the childbirth. ART procedures include stimulation of ovaries to increase the egg production or artificial insemination or combining the sperms and eggs in the laboratory (in vitro) and embryo is transferred to woman to attain the pregnancy.  Asia Pacific assisted reproductive technology (ART) market expected to account for significant share due to rise in infertility cases, late family planning, and availability of technologically advanced fertility services in the region. Latin America assisted reproductive technology market has a notable share in global market owing to expansion of business by the companies, rise in awareness about infertility treatment, and rise in healthcare expenditure are bolster the market. Middle East and Africa assisted reproductive technology market is poised to grow over forecast period owing to economic growth in the Middle East countries and increase in the infertility due to malnutrition in women are expected to upsurge the revenue of market. Obesity and the adoption of bad dietary habits, such as drinking alcohol and smoking, play a significant role in infertility. According to the American Pregnancy Association, infertility affects 30% of men and accounts for about one-fifth of all infertility cases. According to the Centers for Disease Control and Prevention (CDC), 12.1 percent of women between the ages of 15 and 44 are unable to conceive. As a result, an increase in the prevalence of infertility around the world will be a major driving force behind the use of assisted reproductive technologies.